Publications

• The impact of cancer metastases on COVID-19 outcomes: ACOVID-19 and Cancer Consortium registry-based retrospective cohort study.
  Cancer Volume: 130 Page(s): 2191 - 2204
  06/15/2024 Authors: Castellano CA; Sun T; Ravindranathan D; Hwang C; Balanchivadze N; Singh SRK; Griffiths EA; Puzanov I; Ruiz-Garcia E; Vilar-Compte D
• Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
  JCO Precis Oncol Volume: 8 Page(s): e2300567
  04/01/2024 Authors: Park JJ; Chu A; Li J; Ali A; McKay RR; Hwang C; Labriola MK; Jang A; Kilari D; Mo G
• Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
  BMC Cancer Volume: 23 Page(s): 265
  03/23/2023 Authors: Johnson DB; Atkins MB; Hennessy C; Wise-Draper T; Heilman H; Awosika J; Bakouny Z; Labaki C; Saliby RM; Hwang C
• Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
  Oncologist Volume: 28 Page(s): 239 - 245
  03/17/2023 Authors: Zhuang TZ; Ravindranathan D; Liu Y; Martini DJ; Brown JT; Nazha B; Russler G; Yantorni LB; Caulfield S; Carthon BC
• Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
  Oncologist Volume: 27 Page(s): e815 - e818
  10/01/2022 Authors: Zimmerman R; Bilen MA; Heath EI; Nandagopal L; Swami U; Kessel A; Jaeger E; Wesolowski S; Hernanadez EJ; Chipman J
• PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.
  Prostate Cancer Prostatic Dis Volume: 25 Page(s): 388 - 396
  09/01/2022 Authors: Koshkin VS; Patel VG; Ali A; Bilen MA; Ravindranathan D; Park JJ; Kellezi O; Cieslik M; Shaya J; Cabal A
• Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
  Oncologist Volume: 27 Page(s): 462 - 468
  06/08/2022 Authors: Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA
• Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
  Oncologist Volume: 27 Page(s): 220 - 227
  03/11/2022 Authors: Freeman MN; Jang A; Zhu J; Sanati F; Nandagopal L; Ravindranathan D; Desai A; Phone A; Nussenzveig R; Jaeger E
• Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
  JAMA Netw Open Volume: 5 Page(s): e224304
  03/01/2022 Authors: Fu J; Reid SA; French B; Hennessy C; Hwang C; Gatson NT; Duma N; Mishra S; Nguyen R; Hawley JE
• Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
  JAMA Netw Open Volume: 5 Page(s): e2142046
  01/04/2022 Authors: Hawley JE; Sun T; Chism DD; Duma N; Fu JC; Gatson NTN; Mishra S; Nguyen RH; Reid SA; Serrano OK
• Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
  Oncologist Volume: 26 Page(s): 1017 - 1025
  12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
• Thrombocytopenia Induced by Polysulfone Dialysis Membranes.
  Am J Case Rep Volume: 22 Page(s): e932045
  07/03/2021 Authors: Claudio-Gonzalez I; Ravindranathan D; Kempton CL; Bailey JL; Wall SM
• Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
  J Immunother Cancer Volume: 9
  07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
• Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
  Ann Oncol Volume: 32 Page(s): 787 - 800
  06/01/2021 Authors: Grivas P; Khaki AR; Wise-Draper TM; French B; Hennessy C; Hsu C-Y; Shyr Y; Li X; Choueiri TK; Painter CA
• Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
  Oncologist Volume: 26 Page(s): 397 - 405
  05/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS
• Inflammatory Markers in Cancer Immunotherapy.
  Biology (Basel) Volume: 10
  04/13/2021 Authors: Ravindranathan D; Master VA; Bilen MA
• Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series.
  Case Rep Oncol Volume: 14 Page(s): 190 - 196
  01/01/2021 Authors: Ravindranathan D; Russler GA; Yantorni L; Drusbosky LM; Bilen MA
• Landscape of Immunotherapy in Genitourinary Malignancies.
  Adv Exp Med Biol Volume: 1342 Page(s): 143 - 192
  01/01/2021 Authors: Ravindranathan D; Alhalabi O; Rafei H; Shah AY; Bilen MA
• A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
  Cancer Cell Volume: 38 Page(s): 761 - 766
  12/14/2020 Authors: COVID-19 and Cancer Consortium. Electronic address: jeremy.warner@vumc.org; COVID-19 and Cancer Consortium
• EFFICACY OF SEQUENTIAL IMMUNE CHECKPOINT INHIBITION (ICI) IN PATIENTS WITH GENITOURINARY MALIGNANCIES
  Volume: 8 Page(s): A154 - A155
  11/01/2020 Authors: Evans S; Martini D; Magod B; Olsen T; Brown J; Yantorni L; Ravindranathan D; Russler G; Caulfield S; Goldman J
• Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
  Cancer Med Volume: 9 Page(s): 2752 - 2760
  04/01/2020 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Brown J; Hitron EE; Russler GA; Caulfield S; Kissick H; Alemozaffar M
• Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI)
  Volume: 38
  02/20/2020 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS
• Correlation Patterns Among B7 Family Ligands and Tryptophan Degrading Enzymes in Hepatocellular Carcinoma.
  Front Oncol Volume: 10 Page(s): 1632
  01/01/2020 Authors: Chinnadurai R; Scandolara R; Alese OB; Arafat D; Ravindranathan D; Farris AB; El-Rayes BF; Gibson G
• Inflammatory markers at baseline (C1) and cycle 3 (C3) and their association with clinical outcomes in urothelial cancer patients (pts) treated with immunotherapy (IO).
  Volume: 37
  03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
• Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).
  Volume: 37
  03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
• Sites of metastases (mets) and their association with clinical outcomes (CO) in urothelial cancer patients (pts) treated with immunotherapy (IO).
  Volume: 37
  03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
• Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab.
  Clin Genitourin Cancer Volume: 16 Page(s): e563 - e575
  06/01/2018 Authors: Bilen MA; Dutcher GMA; Liu Y; Ravindranathan D; Kissick HT; Carthon BC; Kucuk O; Harris WB; Master VA
• Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the Literature.
  Case Rep Oncol Med Volume: 2018 Page(s): 1809432
  01/01/2018 Authors: Ravindranathan D; Hitron EE; Russler GA; Xue Y; Bilen MA
• THE CAVITARY CONUNDRUM
  Volume: 32 Page(s): S613 - S613
  04/01/2017 Authors: Ravindranathan D; Staloch D; Mody MD; Walker HK
• Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report.
  J Investig Med High Impact Case Rep Volume: 5 Page(s): 2324709617690747
  01/01/2017 Authors: Mody MD; Ravindranathan D; Gill HS; Kota VK
• Highly luminescent tridentate N^C*N platinum(II) complexes featured in fused five-six-membered metallacycle and diminishing concentration quenching.
  Inorg Chem Volume: 50 Page(s): 8261 - 8273
  09/05/2011 Authors: Vezzu DAK; Ravindranathan D; Garner AW; Bartolotti L; Smith ME; Boyle PD; Huo S
• Improvement in phosphorescence efficiency through tuning of coordination geometry of tridentate cyclometalated platinum(II) complexes.
  Inorg Chem Volume: 49 Page(s): 8922 - 8928
  10/04/2010 Authors: Ravindranathan D; Vezzu DAK; Bartolotti L; Boyle PD; Huo S